chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Occupational exposure to product
Clinical narrative: Pharmacist stated that while administering Moderna COVID-19 Vaccine to a pateint, syringe blew off and vaccine leaked out on the floor; This spontaneous case was reported by a health care professional and describes the occurrence of OCCUPATIONAL EXPOSURE TO PRODUCT (Pharmacist stated that while administering Moderna COVID-19 Vaccine to a pateint, syringe blew off and vaccine leaked out on the floor) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced OCCUPATIONAL EXPOSURE TO PRODUCT (Pharmacist stated that while administering Moderna COVID-19 Vaccine to a pateint, syringe blew off and vaccine leaked out on the floor). At the time of the report, OCCUPATIONAL EXPOSURE TO PRODUCT (Pharmacist stated that while administering Moderna COVID-19 Vaccine to a pateint, syringe blew off and vaccine leaked out on the floor) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drugs were reported. No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-035995 (E2B Linked Report).; Reporter's Comments: This case concerns a 31-year-old male who experienced NS events of unexpected occupational exposure to product.  Event onset occurred the same day as mRNA-1273 administration to a patient. The event, occupational exposure to product, is considered resolved.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-035995:same reporter, same events
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain
Clinical narrative: Knee pain; Pain that has settled all over her body; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Knee pain) and PAIN (Pain that has settled all over her body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Knee replacement.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Knee pain) and PAIN (Pain that has settled all over her body). At the time of the report, ARTHRALGIA (Knee pain) and PAIN (Pain that has settled all over her body) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  Treatment medications included ibuprofen.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Nausea, Pyrexia, Tremor
Clinical narrative: nausea; Really bad chills; shaking; fever; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), CHILLS (Really bad chills), TREMOR (shaking) and PYREXIA (fever) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced NAUSEA (nausea), CHILLS (Really bad chills), TREMOR (shaking) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, NAUSEA (nausea), CHILLS (Really bad chills), TREMOR (shaking) and PYREXIA (fever) outcome was unknown.            Concomitant medication were not reported/unknown.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Musculoskeletal discomfort
Clinical narrative: Swollen and sore to the touch lymph node in my neck above my collarbone; Discomfort in neck; Swollen and sore to the touch lymph node in my neck above my collarbone; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen and sore to the touch lymph node in my neck above my collarbone), MUSCULOSKELETAL DISCOMFORT (Discomfort in neck) and LYMPH NODE PAIN (Swollen and sore to the touch lymph node in my neck above my collarbone) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Jan-2021, the patient experienced LYMPHADENOPATHY (Swollen and sore to the touch lymph node in my neck above my collarbone), MUSCULOSKELETAL DISCOMFORT (Discomfort in neck) and LYMPH NODE PAIN (Swollen and sore to the touch lymph node in my neck above my collarbone). The patient was treated with IBUPROFEN for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (Swollen and sore to the touch lymph node in my neck above my collarbone), MUSCULOSKELETAL DISCOMFORT (Discomfort in neck) and LYMPH NODE PAIN (Swollen and sore to the touch lymph node in my neck above my collarbone) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: fatigue that lasted one day/was in bed all that day; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue that lasted one day/was in bed all that day) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue that lasted one day/was in bed all that day). At the time of the report, FATIGUE (fatigue that lasted one day/was in bed all that day) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were not provided.
Age: 32.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: chills; headache; fever; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of   in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and UPADACITINIB (RINVOQ) (Oral) at an unspecified dose.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was reported  No treatment information was provided   Reporter did not allow further contact
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pyrexia
Clinical narrative: fever; chills; banging headache on the left side; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills) and HEADACHE (banging headache on the left side) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L0A) for COVID-19 vaccination.     Concomitant products included VITAMIN D NOS for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced PYREXIA (fever), CHILLS (chills) and HEADACHE (banging headache on the left side). On 25-Jan-2021, PYREXIA (fever), CHILLS (chills) and HEADACHE (banging headache on the left side) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jan-2021, Body temperature: 102 f (High) Fever up to 102 degree Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.   Reporter did not allow further contact
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Numbness facial/ occasional numbness on her cheeks; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness facial/ occasional numbness on her cheeks) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Numbness facial/ occasional numbness on her cheeks). At the time of the report, HYPOAESTHESIA (Numbness facial/ occasional numbness on her cheeks) had not resolved.            No Concomitant Medication available.  No Treatment Medication available.  A week after the first dose patient felt slight numbness intermittently over the right cheek area.  The patient still had numbness on cheeks but not as bad as when got the vaccine. The patient reported had the teeth and eyes checked and the physician informed that the numbness could be the result of the vaccine. The patient also mentioned that the reported lot numbers were wrong but did not provide the corrected one.   This case was linked to MOD-2021-060014 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Batch numbers were deleted. Event verbatim and outcome, action taken and narrative was updated.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Type IV hypersensitivity reaction, Vaccination site erythema, Vaccination site pain
Clinical narrative: Delayed cutaneous hypersensitivity; Roughly circular area that is red; Felt pain at the injection site; fatigue later in the day; Itchy; Slightly swollen; it is a little achy; Hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Felt pain at the injection site), FATIGUE (fatigue later in the day), TYPE IV HYPERSENSITIVITY REACTION (Delayed cutaneous hypersensitivity), VACCINATION SITE ERYTHEMA (Roughly circular area that is red) and VACCINATION SITE PRURITUS (Itchy) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Type 2 diabetes mellitus. Concomitant products included METFORMIN, LOSARTAN, GLICLAZIDE, SERTRALINE, SERTRALINE HYDROCHLORIDE (ZOLOFT) and ETHINYLESTRADIOL, LEVONORGESTREL (LEVORA-28) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE SWELLING (Slightly swollen), PAIN (it is a little achy) and VACCINATION SITE WARMTH (Hot to touch). On 24-Feb-2021, the patient experienced VACCINATION SITE PAIN (Felt pain at the injection site), FATIGUE (fatigue later in the day) and VACCINATION SITE ERYTHEMA (Roughly circular area that is red). On 04-Mar-2021, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (Delayed cutaneous hypersensitivity). The patient was treated with IBUPROFEN at a dose of 400 mg once a day. At the time of the report, VACCINATION SITE PAIN (Felt pain at the injection site), FATIGUE (fatigue later in the day), TYPE IV HYPERSENSITIVITY REACTION (Delayed cutaneous hypersensitivity), VACCINATION SITE ERYTHEMA (Roughly circular area that is red), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE SWELLING (Slightly swollen), PAIN (it is a little achy) and VACCINATION SITE WARMTH (Hot to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Delayed cutaneous hypersensitivity; Roughly circular area that is red; Felt pain at the injection site; fatigue later in the day; Itchy; Slightly swollen; it is a little achy; Hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Felt pain at the injection site), FATIGUE (fatigue later in the day), TYPE IV HYPERSENSITIVITY REACTION (Delayed cutaneous hypersensitivity), VACCINATION SITE ERYTHEMA (Roughly circular area that is red) and VACCINATION SITE PRURITUS (Itchy) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Type 2 diabetes mellitus. Concomitant products included METFORMIN, LOSARTAN, GLICLAZIDE, SERTRALINE, SERTRALINE HYDROCHLORIDE (ZOLOFT) and ETHINYLESTRADIOL, LEVONORGESTREL (LEVORA-28) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE SWELLING (Slightly swollen), PAIN (it is a little achy) and VACCINATION SITE WARMTH (Hot to touch). On 24-Feb-2021, the patient experienced VACCINATION SITE PAIN (Felt pain at the injection site), FATIGUE (fatigue later in the day) and VACCINATION SITE ERYTHEMA (Roughly circular area that is red). On 04-Mar-2021, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (Delayed cutaneous hypersensitivity). The patient was treated with IBUPROFEN at a dose of 400 mg once a day. At the time of the report, VACCINATION SITE PAIN (Felt pain at the injection site), FATIGUE (fatigue later in the day), TYPE IV HYPERSENSITIVITY REACTION (Delayed cutaneous hypersensitivity), VACCINATION SITE ERYTHEMA (Roughly circular area that is red), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE SWELLING (Slightly swollen), PAIN (it is a little achy) and VACCINATION SITE WARMTH (Hot to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: itchiness in right arm; swelling in right arm; redness in right arm; some pain bottom side of arm under injection site; queasy stomach; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (queasy stomach), VACCINATION SITE PRURITUS (itchiness in right arm), VACCINATION SITE SWELLING (swelling in right arm), VACCINATION SITE ERYTHEMA (redness in right arm) and VACCINATION SITE PAIN (some pain bottom side of arm under injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (queasy stomach). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itchiness in right arm), VACCINATION SITE SWELLING (swelling in right arm), VACCINATION SITE ERYTHEMA (redness in right arm) and VACCINATION SITE PAIN (some pain bottom side of arm under injection site). At the time of the report, ABDOMINAL DISCOMFORT (queasy stomach), VACCINATION SITE PRURITUS (itchiness in right arm), VACCINATION SITE SWELLING (swelling in right arm), VACCINATION SITE ERYTHEMA (redness in right arm) and VACCINATION SITE PAIN (some pain bottom side of arm under injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant product usage were not reported by the reporter. No treatment details were added.
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Pain hurting very badly; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain hurting very badly) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. MOD011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN (Pain hurting very badly). At the time of the report, PAIN (Pain hurting very badly) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication were reported. Treatment medication includes Aleve.
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: After the needle entered his arm, there was fluid that ran to the back of his arm to the elbow; This spontaneous case was reported by a patient family member or friend and describes the occurrence of UNDERDOSE (After the needle entered his arm, there was fluid that ran to the back of his arm to the elbow) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced UNDERDOSE (After the needle entered his arm, there was fluid that ran to the back of his arm to the elbow). On 04-Mar-2021, UNDERDOSE (After the needle entered his arm, there was fluid that ran to the back of his arm to the elbow) had resolved.            This report refers to a case of vaccine underdose for mRNA-1273, lot #031M20A, with no associated AEs.; Sender's Comments: This report refers to a case of vaccine underdose for mRNA-1273, lot #031M20A, with no associated AEs.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient missed her second dose and now it has been >42 days that she still hasn't received her second dose; A spontaneous report was received from a other health professional concerning a 55-years-old female patient, who received Moderna's covid-19 vaccine (mRNA -1273) and missed her second dose(inappropriate schedule of product administration).  The patient's medical history was not provided. Concomitant medications were not reported.  On 18 JAN 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 037K20H(?)) intramuscularly for prophylaxis of COVID-19 infection.    On 18 JAN 2021, the patient received the mRNA-1273 vaccine and missed her second dose now it has been more than 42 days that she still hasn't received her second dose. Treatment details were not provided.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the event missed second dose was considered to be resolved.; Reporter's Comments: This report refers to a 55-years-old female patient who missed her second dose and now it has been >42 days that she still hasn't received her second dose (product dose omission) for mRNA-1273. There were no reported AEs associated with this case of product dose omission.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: tested positive for covid-19 after dose 1, but had symptoms before; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for covid-19 after dose 1, but had symptoms before) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included METHOTREXATE for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (tested positive for covid-19 after dose 1, but had symptoms before). At the time of the report, COVID-19 (tested positive for covid-19 after dose 1, but had symptoms before) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include Methotrexate, Eloquis, Blood pressure. Treatment information not provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Peripheral swelling, Pyrexia, Tremor
Clinical narrative: shaking; Nauseated out of deep sleep; feverish; Swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), TREMOR (shaking), NAUSEA (Nauseated out of deep sleep) and PYREXIA (feverish) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm). On an unknown date, the patient experienced TREMOR (shaking), NAUSEA (Nauseated out of deep sleep) and PYREXIA (feverish). At the time of the report, PERIPHERAL SWELLING (Swollen arm), TREMOR (shaking), NAUSEA (Nauseated out of deep sleep) and PYREXIA (feverish) outcome was unknown.            No concomitant medication information was reported. Reporter stated that patient was asked to take Tylenol but couldn't take the medication at that moment due to the nausea.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling, Swollen tongue
Clinical narrative: Mild throat swelling; Mild tongue swelling; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Mild throat swelling) and SWOLLEN TONGUE (Mild tongue swelling) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PHARYNGEAL SWELLING (Mild throat swelling) and SWOLLEN TONGUE (Mild tongue swelling). On 05-Mar-2021, PHARYNGEAL SWELLING (Mild throat swelling) and SWOLLEN TONGUE (Mild tongue swelling) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient stated that she is doing fine and is yet to take her second dose.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Follow-up received on 02-May-2021 contains non-significant information.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Peripheral swelling
Clinical narrative: swollen arm; minor itch; redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm), INJECTION SITE PRURITUS (minor itch) and INJECTION SITE ERYTHEMA (redness at injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PERIPHERAL SWELLING (swollen arm), INJECTION SITE PRURITUS (minor itch) and INJECTION SITE ERYTHEMA (redness at injection site). At the time of the report, PERIPHERAL SWELLING (swollen arm), INJECTION SITE PRURITUS (minor itch) and INJECTION SITE ERYTHEMA (redness at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant and treatment medications information was reported.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced FATIGUE (Tiredness). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 04-Feb-2021, FATIGUE (Tiredness) had resolved.            This case was linked to MOD-2021-060833 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pruritus
Clinical narrative: Itching on her face and abdomen; Headache; This spontaneous case was reported by a nurse and describes the occurrence of PRURITUS (Itching on her face and abdomen) and HEADACHE (Headache) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching on her face and abdomen) and HEADACHE (Headache). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching, at a dose of 25 milligram Po. At the time of the report, PRURITUS (Itching on her face and abdomen) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow-up received and contains no new information.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dyspnoea, Eye pain, Headache, Heart rate irregular
Clinical narrative: could not breathe; pain in arm; hard to lift arm off pillow; weakness; blurred vision; pain behind eyes; irregular heartbeat; headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (could not breathe), PAIN IN EXTREMITY (pain in arm), MUSCULAR WEAKNESS (hard to lift arm off pillow), ASTHENIA (weakness) and VISION BLURRED (blurred vision) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Surgery (Patient stated that she has undergone surgery a month before receiving the vaccine.). Concurrent medical conditions included Allergy multiple. Concomitant products included NADOLOL (CORGARD), CANDESARTAN CILEXETIL (ATACAND) and CLONIDINE for an unknown indication.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced DYSPNOEA (could not breathe), PAIN IN EXTREMITY (pain in arm), MUSCULAR WEAKNESS (hard to lift arm off pillow), ASTHENIA (weakness), VISION BLURRED (blurred vision), EYE PAIN (pain behind eyes), HEART RATE IRREGULAR (irregular heartbeat) and HEADACHE (headache). At the time of the report, DYSPNOEA (could not breathe), PAIN IN EXTREMITY (pain in arm), MUSCULAR WEAKNESS (hard to lift arm off pillow), ASTHENIA (weakness), VISION BLURRED (blurred vision), EYE PAIN (pain behind eyes), HEART RATE IRREGULAR (irregular heartbeat) and HEADACHE (headache) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   Concomitant medications include diabetic medications.  No treatment medications were reported.   This case was linked to MOD-2021-263014 (Patient Link).  Most recent FOLLOW-UP information incorporated above includes: On 01-May-2021: NNI On 21-Jul-2021: Updated event outcome. Added second dose events.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Pain in extremity, Vision blurred
Clinical narrative: could not breathe; pain in arm; hard to lift arm off pillow; weakness; blurred vision; pain behind eyes; irregular heartbeat; headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (could not breathe), PAIN IN EXTREMITY (pain in arm), MUSCULAR WEAKNESS (hard to lift arm off pillow), ASTHENIA (weakness) and VISION BLURRED (blurred vision) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Surgery (Patient stated that she has undergone surgery a month before receiving the vaccine.). Concurrent medical conditions included Allergy multiple. Concomitant products included NADOLOL (CORGARD), CANDESARTAN CILEXETIL (ATACAND) and CLONIDINE for an unknown indication.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced DYSPNOEA (could not breathe), PAIN IN EXTREMITY (pain in arm), MUSCULAR WEAKNESS (hard to lift arm off pillow), ASTHENIA (weakness), VISION BLURRED (blurred vision), EYE PAIN (pain behind eyes), HEART RATE IRREGULAR (irregular heartbeat) and HEADACHE (headache). At the time of the report, DYSPNOEA (could not breathe), PAIN IN EXTREMITY (pain in arm), MUSCULAR WEAKNESS (hard to lift arm off pillow), ASTHENIA (weakness), VISION BLURRED (blurred vision), EYE PAIN (pain behind eyes), HEART RATE IRREGULAR (irregular heartbeat) and HEADACHE (headache) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   Concomitant medications include diabetic medications.  No treatment medications were reported.   This case was linked to MOD-2021-263014 (Patient Link).  Most recent FOLLOW-UP information incorporated above includes: On 01-May-2021: NNI On 21-Jul-2021: Updated event outcome. Added second dose events.
Sex: U
Vaccine: COVID19
Symptoms: Abdominal pain, Chills, Pyrexia
Clinical narrative: Intestinal Pain; Chills; fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Intestinal Pain), PYREXIA (fever) and CHILLS (Chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 042L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (fever). On 04-Mar-2021, the patient experienced ABDOMINAL PAIN (Intestinal Pain) and CHILLS (Chills). On 20-Feb-2021, PYREXIA (fever) had resolved. At the time of the report, ABDOMINAL PAIN (Intestinal Pain) and CHILLS (Chills) outcome was unknown.            No Concomitant and treatment medications information was reported.
Sex: M
Vaccine: COVID19, UNK
Symptoms: Faeces pale, Headache
Clinical narrative: stool light colored; headache; This spontaneous case was reported by a consumer and describes the occurrence of   in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product GLECAPREVIR, PIBRENTASVIR (MAVYRET) for an unknown indication.    No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient started GLECAPREVIR, PIBRENTASVIR (MAVYRET) (Oral) at an unspecified dose.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's relevant concomitant medications weren't reported Treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: NNI On 28-May-2021: NNI
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Night sweats, Pyrexia
Clinical narrative: Night sweats; Pain at injection site; Fever >101F; Rigors; body aches for about 4-5 days; generalized fatigue; This spontaneous case was reported by a physician and describes the occurrence of NIGHT SWEATS (Night sweats), VACCINATION SITE PAIN (Pain at injection site), FATIGUE (generalized fatigue), PYREXIA (Fever >101F) and CHILLS (Rigors) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 from 23-Jan-2021 to 13-Feb-2021.    On 02-Mar-2021 at 12:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced FATIGUE (generalized fatigue). On 03-Mar-2021, the patient experienced NIGHT SWEATS (Night sweats), VACCINATION SITE PAIN (Pain at injection site), PYREXIA (Fever >101F), CHILLS (Rigors) and MYALGIA (body aches for about 4-5 days). On 06-Mar-2021, NIGHT SWEATS (Night sweats), VACCINATION SITE PAIN (Pain at injection site), PYREXIA (Fever >101F), CHILLS (Rigors) and MYALGIA (body aches for about 4-5 days) had resolved. At the time of the report, FATIGUE (generalized fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was treated with over the counter NSAID (Motrin and Tylenol).   This case was linked to MOD-2021-105140 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Reporter details, Patient's demographic information, Past medical history, Product details, Outcome of events with recovered dates, 2nd vaccine information was provided by the reporter.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Night sweats; Pain at injection site; Fever >101F; Rigors; body aches for about 4-5 days; generalized fatigue; This spontaneous case was reported by a physician and describes the occurrence of NIGHT SWEATS (Night sweats), VACCINATION SITE PAIN (Pain at injection site), FATIGUE (generalized fatigue), PYREXIA (Fever >101F) and CHILLS (Rigors) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 from 23-Jan-2021 to 13-Feb-2021.    On 02-Mar-2021 at 12:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced FATIGUE (generalized fatigue). On 03-Mar-2021, the patient experienced NIGHT SWEATS (Night sweats), VACCINATION SITE PAIN (Pain at injection site), PYREXIA (Fever >101F), CHILLS (Rigors) and MYALGIA (body aches for about 4-5 days). On 06-Mar-2021, NIGHT SWEATS (Night sweats), VACCINATION SITE PAIN (Pain at injection site), PYREXIA (Fever >101F), CHILLS (Rigors) and MYALGIA (body aches for about 4-5 days) had resolved. At the time of the report, FATIGUE (generalized fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was treated with over the counter NSAID (Motrin and Tylenol).   This case was linked to MOD-2021-105140 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Reporter details, Patient's demographic information, Past medical history, Product details, Outcome of events with recovered dates, 2nd vaccine information was provided by the reporter.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at a dose of UNK dosage form. At the time of the report, HEADACHE (headache) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medications was not provided.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Feeling hot, Myalgia, Nausea
Clinical narrative: Diarrhea; Nausea; Chills; Bodyache; Shooting pain down the left arm; Whole body was on fire; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Shooting pain down the left arm), FEELING HOT (Whole body was on fire), DIARRHOEA (Diarrhea), CHILLS (Chills) and MYALGIA (Bodyache) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021 at 4:00 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Shooting pain down the left arm), FEELING HOT (Whole body was on fire), CHILLS (Chills) and MYALGIA (Bodyache). On 06-Mar-2021, the patient experienced DIARRHOEA (Diarrhea) and NAUSEA (Nausea). At the time of the report, PAIN IN EXTREMITY (Shooting pain down the left arm), FEELING HOT (Whole body was on fire), CHILLS (Chills) and MYALGIA (Bodyache) outcome was unknown and DIARRHOEA (Diarrhea) and NAUSEA (Nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.    Reporter did not allow further contact
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Diarrhea; Nausea; Chills; Bodyache; Shooting pain down the left arm; Whole body was on fire; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Shooting pain down the left arm), FEELING HOT (Whole body was on fire), DIARRHOEA (Diarrhea), CHILLS (Chills) and MYALGIA (Bodyache) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021 at 4:00 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Shooting pain down the left arm), FEELING HOT (Whole body was on fire), CHILLS (Chills) and MYALGIA (Bodyache). On 06-Mar-2021, the patient experienced DIARRHOEA (Diarrhea) and NAUSEA (Nausea). At the time of the report, PAIN IN EXTREMITY (Shooting pain down the left arm), FEELING HOT (Whole body was on fire), CHILLS (Chills) and MYALGIA (Bodyache) outcome was unknown and DIARRHOEA (Diarrhea) and NAUSEA (Nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.    Reporter did not allow further contact
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: Arm red; Arm itch; Arm rash; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm red), PRURITUS (Arm itch) and RASH (Arm rash) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced ERYTHEMA (Arm red), PRURITUS (Arm itch) and RASH (Arm rash). At the time of the report, ERYTHEMA (Arm red), PRURITUS (Arm itch) and RASH (Arm rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment included none
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This spontaneous case was reported by a health care professional and describes the occurrence of HERPES ZOSTER (Shingles) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Medical history was not reported).    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced HERPES ZOSTER (Shingles). At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information included pain killers.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Decreased appetite, Diarrhoea, Headache
Clinical narrative: Diarrhea; Very little appetite; nausea; Headache; chills; Pain in the arm at the injection site; Stomachache; shaking; sweating; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomachache), NAUSEA (nausea), TREMOR (shaking), CHILLS (chills) and HYPERHIDROSIS (sweating) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012AZIA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (NO MEDICAL HISTORY.).    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomachache), NAUSEA (nausea), TREMOR (shaking), CHILLS (chills), HYPERHIDROSIS (sweating), VACCINATION SITE PAIN (Pain in the arm at the injection site) and HEADACHE (Headache). On 05-Mar-2021, the patient experienced DIARRHOEA (Diarrhea) and DECREASED APPETITE (Very little appetite). At the time of the report, ABDOMINAL PAIN UPPER (Stomachache), NAUSEA (nausea), TREMOR (shaking), CHILLS (chills), HYPERHIDROSIS (sweating), VACCINATION SITE PAIN (Pain in the arm at the injection site), HEADACHE (Headache), DIARRHOEA (Diarrhea) and DECREASED APPETITE (Very little appetite) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications was given. No treatment information was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Nausea, Tremor, Vaccination site pain
Clinical narrative: Diarrhea; Very little appetite; nausea; Headache; chills; Pain in the arm at the injection site; Stomachache; shaking; sweating; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomachache), NAUSEA (nausea), TREMOR (shaking), CHILLS (chills) and HYPERHIDROSIS (sweating) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012AZIA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (NO MEDICAL HISTORY.).    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomachache), NAUSEA (nausea), TREMOR (shaking), CHILLS (chills), HYPERHIDROSIS (sweating), VACCINATION SITE PAIN (Pain in the arm at the injection site) and HEADACHE (Headache). On 05-Mar-2021, the patient experienced DIARRHOEA (Diarrhea) and DECREASED APPETITE (Very little appetite). At the time of the report, ABDOMINAL PAIN UPPER (Stomachache), NAUSEA (nausea), TREMOR (shaking), CHILLS (chills), HYPERHIDROSIS (sweating), VACCINATION SITE PAIN (Pain in the arm at the injection site), HEADACHE (Headache), DIARRHOEA (Diarrhea) and DECREASED APPETITE (Very little appetite) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications was given. No treatment information was provided.